-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TTX-030 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TTX-030 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TTX-030 in Solid Tumor Drug Details: TTX-030 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ELVN-002 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ELVN-002 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ELVN-002 in Non-Small Cell Lung Cancer Drug Details: ELVN-002 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – QBS-10072S in Cervical Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. QBS-10072S in Cervical Cancer Drug Details: QBS-10072S is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Disufenton Sodium in Glioblastoma Multiforme (GBM)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Disufenton Sodium in Glioblastoma Multiforme (GBM) Drug Details: Disufenton sodium (NXY-059, OKN-007) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NuGel in Sepsis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NuGel in Sepsis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.NuGel in SepsisDrug Details:NuGel (sodium taurodeoxycholic acid) is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LY-01011 in Multiple Myeloma (Kahler Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LY-01011 in Multiple Myeloma (Kahler Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LY-01011 in Multiple Myeloma (Kahler Disease) Drug Details: Denosumab biosimilar...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – influenza [strain A/Singapore/INFIMH-16-0019/2016 (H3N2)] (monovalent) vaccine in Influenza A Virus, H3N2 Subtype Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Influenza [Strain A/Singapore/Infimh-16-0019/2016 (H3N2)] (Monovalent) Vaccine in Influenza A Virus, H3N2 Subtype Infections Drug Details:Influenza vaccine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cellular Immunotherapy for Hematological Malignancy and Solid Tumor in Refractory Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cellular Immunotherapy for Hematological Malignancy and Solid Tumor in Refractory Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cellular Immunotherapy...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – HH-2853 in Peripheral T-Cell Lymphomas (PTCL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HH-2853 in Peripheral T-Cell Lymphomas (PTCL) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HH-2853 in Peripheral T-Cell Lymphomas (PTCL) Drug Details: HH-2853...
-
Product Insights
Inhalers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Inhalers Pipeline Market Report Overview Inhalers deliver medication to the lungs. The inhalers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segment ·       Dry Powder Inhaler Devices Key Territories ·       The US ·       Europe ·       Australia...